Papers - HATAKEYAMA SHINGO
-
The impact of microalbuminuria on overactive bladders: Results from a community‐based four‐year longitudinal study in Japan
Teppei Okamoto, Shingo Hatakeyama, Masataka Ando, Jung Songee, Atsushi Imai, Itsuto Hamano, Naoki Fujita, Akiko Okamoto, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Neurourology and Urodynamics 39 ( 5 ) 1567 - 1575 2020.5
-
特集 ここが変わった! 膀胱癌診療-新ガイドラインを読み解く StageⅡおよびⅢ膀胱癌の治療
濱野 逸人, 畠山 真吾, 大山 力
臨床泌尿器科 74 ( 5 ) 312 - 315 2020.4
-
増刊号特集 泌尿器科診療の最新スタンダード-平成の常識は令和の非常識 腫瘍 部位別 膀胱癌:手術治療(膀胱全摘除術)
畠山 真吾, 米山 高弘, 大山 力
臨床泌尿器科 74 ( 4 ) 45 - 48 2020.4
-
Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan‐Japan UTUC Collaboration Cohort
Hao Lun Luo, Chikara Ohyama, Shingo Hatakeyama, Hung Jen Wang, Tohru Yoneyama, Wen Chou Yang, Yao Chi Chuang, Yen Ta Chen, Wei Chin Lee, Yuan Tso Cheng, Chih Hsiung Kang, Po Hui Chiang
International Journal of Urology 27 ( 4 ) 327 - 332 2020.4
-
特集 Cl-:電解質のクイーン 臨床とCl- 尿路変向術に伴う高Cl血症
濱野 逸人, 畠山 真吾, 大山 力
腎と透析 88 ( 3 ) 411 - 414 2020.3
-
The association between serum serotonin levels and overactive bladder: results from a community-based cross-sectional study in Japan.
Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama
World journal of urology 2020.3
-
The association between gut microbiome and erectile dysfunction: a community-based cross-sectional study in Japan.
Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama
International urology and nephrology 2020.3
-
STone Episode Prediction: Development and validation of the prediction nomogram for urolithiasis.
Kazutaka Okita, Shingo Hatakeyama, Atsushi Imai, Toshikazu Tanaka, Itsuto Hamano, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 2020.3
-
Editorial Comment to Incidence and risk factors of postoperative delirium in elderly patients undergoing urological surgery: A multi-institutional prospective study.
Shingo Hatakeyama, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 3 ) 225 - 226 2020.3
-
Avelumab plus axitinib vs sunitinib for advanced renal cell carcinoma: Japanese subgroup analysis from JAVELIN Renal 101.
Motohide Uemura, Yoshihiko Tomita, Hideaki Miyake, Shingo Hatakeyama, Hiro-Omi Kanayama, Kazuyuki Numakura, Toshio Takagi, Tomoyuki Kato, Masatoshi Eto, Wataru Obara, Hirotsugu Uemura, Toni K Choueiri, Robert J Motzer, Yosuke Fujii, Yoichi Kamei, Yoshiko Umeyama, Alessandra di Pietro, Mototsugu Oya
Cancer science 111 ( 3 ) 907 - 923 2020.3
-
Unusual presentation of upper urinary tract urothelial carcinoma in Taiwan: Direct comparison from Taiwan-Japan UTUC Collaboration Cohort.
Hao Lun Luo, Chikara Ohyama, Shingo Hatakeyama, Hung Jen Wang, Tohru Yoneyama, Wen Chou Yang, Yao Chi Chuang, Yen Ta Chen, Wei Chin Lee, Yuan Tso Cheng, Chih Hsiung Kang, Po Hui Chiang
International journal of urology : official journal of the Japanese Urological Association 2020.2
-
Serum N-glycan profiling can predict biopsy-proven graft rejection after living kidney transplantation.
Osamu Soma, Shingo Hatakeyama, Tohru Yoneyama, Mitsuru Saito, Hideo Sasaki, Yuki Tobisawa, Daisuke Noro, Yuichiro Suzuki, Masakazu Tanaka, Shin-Ichiro Nishimura, Hiroshi Harada, Hideki Ishida, Kazunari Tanabe, Shigeru Satoh, Chikara Ohyama
Clinical and experimental nephrology 24 ( 2 ) 174 - 184 2020.2
-
Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.
Sappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, Yuka Kubota, Yuichiro Suzuki, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Kazuyuki Mori, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of clinical oncology 25 ( 2 ) 362 - 369 2020.2
-
Clinical outcomes and prognostic factors in patients with newly diagnosed metastatic prostate cancer initially treated with androgen deprivation therapy: a retrospective multicenter study in Japan.
Shintaro Narita, Shingo Hatakeyama, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Atsushi Koizumi, Koji Mitsuzuka, Tatsuo Tochigi, Norihiko Tsuchiya, Chikara Ohyama, Yoichi Arai, Kyoko Nomura, Tomonori Habuchi
International journal of clinical oncology 2020.1
-
Validation and development of the CHAARTED criteria in patients with hormone-naïve metastatic prostate cancer: A multi-institutional retrospective study in Japan.
Teppei Okamoto, Shingo Hatakeyama, Shintaro Narita, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 1 ) 90 - 91 2020.1
-
ヌーナン症候群患者に施行した献腎移植
小玉 寛健, 畠山 真吾, 村澤 洋美, 杉山 尚樹, 岡本 亜希子, 山本 勇人, 北原 竜次, 米山 高弘, 橋本 安弘, 齋藤 久夫, 大山 力
移植 55 ( Supplement ) 365_1 - 365_1 2020
-
当科におけるABO不適合移植の移植成績
濱谷 智子, 濱野 逸人, 畠山 真吾, 藤田 雄, 村上 礼一, 岡本 哲平, 鈴木 裕一朗, 山本 勇人, 米山 徹, 米山 高弘, 橋本 安弘, 齋藤 久夫, 鈴木 唯司, 大山 力
移植 55 ( Supplement ) 360_1 - 360_1 2020
-
前立腺がんの過剰診断・過剰治療を回避する糖鎖関連バイオマーカー
米山 徹, 飛澤 悠葵, 畠山 真吾, 大山 力
泌尿器科 11(1) 99 - 110 2020
-
マージナルドナーからの生体腎移植における移植成績ならびにドナー・レシピエント腎機能の検討
濱野 逸人, 畠山 真吾, 濱谷 智子, 百田 匡毅, 成田 拓磨, 小島 由太, 岩村 大径, 米山 徹, 岡本 哲平, 山本 勇人, 米山 高弘, 橋本 安弘, 大山 力
移植 55 ( Supplement ) 356_1 - 356_1 2020
-
ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘術 (RARP) の治療成績
米山 高弘, 濱谷 智子, 百田 匡毅, 濱野 逸人, 成田 拓磨, 岩村 大径, 小島 由太, 岡本 哲平, 山本 勇人, 今井 篤, 畠山 真吾, 橋本 安弘, 大山 力
Japanese Journal of Endourology 33 ( 2 ) 325 - 329 2020